Dankers, M.
van den Berk-Bulsink, M. J. E.
van Dalfsen-Slingerland, M.
Nelissen-Vrancken, H.J.M.G.
Mantel-Teeuwisse, A. K.
van Dijk, L.
Article History
Received: 29 November 2021
Accepted: 1 June 2022
First Online: 13 June 2022
Declarations
:
: According to Dutch law, no ethics approval was obligatory for this type of study, since the participating health care professionals were not exposed to interventions [CitationRef removed]. All participants of the focus group discussion gave written informed consent before the start of the focus group discussions. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Dankers M, Van den Berk-Bulsink MJE, Slingerland-van Dalfsen M, Nelissen-Vrancken HJMG and Mantel-Teeuwisse AK declare that they have no competing interests. Van Dijk L received an unrestricted grant from TEVA Pharmaceuticals for a research project not related to this study.